Latest Breaking News On - Lilly zepbound - Page 1 : comparemela.com

Gilead Stock Jumps After Its Weight-Loss Drug Emerges From Under The Radar

Gilead stock jumped Friday after surprising Wall Street with preclinical test results for an under-the-radar weight-loss drug.

Weight-loss drug forecasts jump to $150 billion as supply grows

As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly , increasing supplies, possible wider usage and a growing number of would-be rivals are leading some experts to raise annual global sales forecasts for the treatments to about $150 billion by the early 2030s.

Weight-loss drug sale forecasts jump to $150bn as supply grows

Over 80 experimental obesity drugs have reached the human testing stage

Obesity Drug Stocks: Where to Invest Now

Analysis-Weight-loss drug forecasts jump to $150 billion as supply grows